RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections


Motsch J., de Oliveira C. M. , Stus V., Koksal I. , Lyulko O., Boucher H. W. , ...Daha Fazla

CLINICAL INFECTIOUS DISEASES, cilt.70, sa.9, ss.1799-1808, 2020 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 70 Konu: 9
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1093/cid/ciz530
  • Dergi Adı: CLINICAL INFECTIOUS DISEASES
  • Sayfa Sayıları: ss.1799-1808

Özet

Background: The beta-lactamase inhibitor relebactam can restore imipenem activity against imipenem-nonsusceptible gram-negative pathogens. We evaluated imipenem/relebactam for treating imipenem-nonsusceptible infections.